These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 1834072)

  • 1. The serotonin connection in OCD. Comments on "Recent advances in obsessive-compulsive disorder".
    Murphy DL
    Neuropsychopharmacology; 1991 Aug; 5(1):11-12; discussion 21-2. PubMed ID: 1834072
    [No Abstract]   [Full Text] [Related]  

  • 2. Has OCD research gone to the dogs? Comments on "Recent advances in obsessive-compulsive disorder".
    Insel TR
    Neuropsychopharmacology; 1991 Aug; 5(1):13-7; discussion 21-2. PubMed ID: 1930607
    [No Abstract]   [Full Text] [Related]  

  • 3. Update of the serotonergic hypothesis of obsessive compulsive disorder.
    Zohar J; Kindler S
    Clin Neuropharmacol; 1992; 15 Suppl 1 Pt A():257A-258A. PubMed ID: 1386779
    [No Abstract]   [Full Text] [Related]  

  • 4. Neurobiology of obsessive compulsive disorder: a possible role for serotonin.
    Winslow JT; Insel TR
    J Clin Psychiatry; 1990 Aug; 51 Suppl():27-31; discussion 55-8. PubMed ID: 2199432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 5-HT2A/C receptors do not mediate the attenuation of compulsive checking by mCPP in the quinpirole sensitization rat model of obsessive-compulsive disorder (OCD).
    Tucci MC; Dvorkin-Gheva A; Johnson E; Wong M; Szechtman H
    Behav Brain Res; 2015 Feb; 279():211-7. PubMed ID: 25449840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The serotonin hypothesis of obsessive compulsive disorder: implications of pharmacologic challenge studies.
    Barr LC; Goodman WK; Price LH; McDougle CJ; Charney DS
    J Clin Psychiatry; 1992 Apr; 53 Suppl():17-28. PubMed ID: 1532961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The combined effects of memantine and fluoxetine on an animal model of obsessive compulsive disorder.
    Wald R; Dodman N; Shuster L
    Exp Clin Psychopharmacol; 2009 Jun; 17(3):191-7. PubMed ID: 19586234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A review of animal models of obsessive-compulsive disorder: a focus on developmental, immune, endocrine and behavioral models.
    Grados M; Prazak M; Saif A; Halls A
    Expert Opin Drug Discov; 2016; 11(1):27-43. PubMed ID: 26558411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5-HT2c receptor activation induces grooming behaviour in rats: possible correlations with obsessive-compulsive disorder.
    Gráf M
    Neuropsychopharmacol Hung; 2006 Mar; 8(1):23-8. PubMed ID: 16841562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The neuroethological approach to obsessive-compulsive disorder.
    Stein DJ; Shoulberg N; Helton K; Hollander E
    Compr Psychiatry; 1992; 33(4):274-81. PubMed ID: 1643870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Animal models in obsessive compulsive disorder.
    Olivier B
    Int Clin Psychopharmacol; 1992 Jun; 7 Suppl 1():27-9. PubMed ID: 1517553
    [No Abstract]   [Full Text] [Related]  

  • 12. Mood-related obsessive-compulsive symptoms in a patient with bipolar affective disorder.
    Gordon A; Rasmussen SA
    J Clin Psychiatry; 1988 Jan; 49(1):27-8. PubMed ID: 3335487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent advances in obsessive-compulsive disorder.
    Rapoport JL
    Neuropsychopharmacology; 1991 Aug; 5(1):1-10. PubMed ID: 1930606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparative examination of a role for serotonin in obsessive compulsive disorder, panic disorder, and anxiety.
    Murphy DL; Pigott TA
    J Clin Psychiatry; 1990 Apr; 51 Suppl():53-8; discussion 59-60. PubMed ID: 2139026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroscience: obsessed with grooming.
    Hyman SE
    Nature; 2007 Aug; 448(7156):871-2. PubMed ID: 17713517
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of glutamate-related drugs on marble-burying behavior in mice: implications for obsessive-compulsive disorder.
    Egashira N; Okuno R; Harada S; Matsushita M; Mishima K; Iwasaki K; Nishimura R; Oishi R; Fujiwara M
    Eur J Pharmacol; 2008 May; 586(1-3):164-70. PubMed ID: 18423440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beyond the serotonin hypothesis: a role for dopamine in some forms of obsessive compulsive disorder?
    Goodman WK; McDougle CJ; Price LH; Riddle MA; Pauls DL; Leckman JF
    J Clin Psychiatry; 1990 Aug; 51 Suppl():36-43; discussion 55-8. PubMed ID: 2199433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Animal models of obsessive-compulsive disorder: rationale to understanding psychobiology and pharmacology.
    Korff S; Harvey BH
    Psychiatr Clin North Am; 2006 Jun; 29(2):371-90. PubMed ID: 16650714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The waking nightmare: an overview of obsessive compulsive disorder.
    Rapoport JL
    J Clin Psychiatry; 1990 Nov; 51 Suppl():25-8. PubMed ID: 2228991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The potential role of serotonin reuptake inhibitors in the treatment of obsessive compulsive disorder.
    Zak JP; Miller JA; Sheehan DV; Fanous BS
    J Clin Psychiatry; 1988 Aug; 49 Suppl():23-9. PubMed ID: 3045108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.